Bioporto Sees FY 2023 Revenue Between Approximately DKK 30 Mln To 33 Mln

March 30, 2023 07:54 AM AEDT | By Reuters
Follow us on Google News:

March 29 (Reuters) - Bioporto A/S:

* BIOPORTO ANNOUNCES FINANCIAL GUIDANCE FOR 2023

* SEES FY23 REVENUE BETWEEN APPROXIMATELY DKK 30 MILLION TO 33 MILLION

* WHILE FDA APPROVAL IS PENDING, COSTS RELATED TO FUTURE CLINICAL STUDIES ARE ASSUMED TO BE LOWER THAN IN 2022

* SEES 2023 ADJUSTED EBITDA LOSS OF APPROXIMATELY DKK 60 MILLION TO DKK 65 MILLION Source text for Eikon: Further company coverage:


Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.



Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK